Who owns Aptevo Therapeutics Inc Com New stock?
- Ticker: APVO
- CUSIP Number: 03835l207
Tip: Access positions for across all investors
Analyze quarterly positions in Aptevo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aptevo Therapeutics stock
Who bought or sold Aptevo Therapeutics Inc Com New stock this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Sabby Management | 1.3M | $440k | 100% | Sep 2023 |
|
Armistice Capital | 1.2M | $408k | 100% | Sep 2023 |
|
Citadel Advisors | 262k | $47k | 100% | Dec 2023 |
|
Renaissance Technologies | 176k | $58k | 119% | Sep 2023 |
|
Schonfeld Strategic Advisors | 159k | $29k | 11% | Dec 2023 |
|
Squarepoint Ops | 139k | $25k | 100% | Dec 2023 |
|
Millennium Management | 105k | $19k | 100% | Dec 2023 |
|
Vanguard Group | 92k | $17k | -59% | Dec 2023 |
|
Geode Capital Management | 75k | $25k | 43% | Sep 2023 |
|
Cantor Fitzgerald, L. P. | 59k | $11k | 4% | Dec 2023 |
|
BlackRock | 48k | $16k | -1% | Sep 2023 |
|
Alyeska Investment Group | 46k | $8.3k | 100% | Dec 2023 |
|
Baader Bank | 15k | $2.0k | 100% | Dec 2023 |
|
Northern Trust | 14k | $4.7k | -20% | Sep 2023 |
|
Tower Research Capital | 14k | $4.5k | 806% | Sep 2023 |
|
Two Sigma Securities | 11k | $2.0k | 100% | Dec 2023 |
|
Morgan Stanley | 11k | $3.6k | 0% | Sep 2023 |
|
Franklin Resources | 11k | $2.0k | 0% | Dec 2023 |
|
State Street Corporation | 11k | $3.6k | 0% | Sep 2023 |
|
Divergent Wealth Advisors | 10k | $1.8k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 1.9k | $342.977600 | -1% | Dec 2023 |
|
Wells Fargo & Company | 1.6k | $292.838700 | 4% | Dec 2023 |
|
Fifth Third Bancorp | 291.00 | $52.991100 | 0% | Dec 2023 |
|
Pnc Financial Services | 142.00 | $26.000200 | 0% | Dec 2023 |
|
Truvestments Capital | 95.00 | $30.998500 | 0% | Sep 2023 |
|
Advisor Group Holdings | 30.00 | $5.001000 | 0% | Dec 2023 |
|
Hanson McClain Advisors | 17.00 | $4.000100 | 0% | Dec 2023 |
|
Citigroup | 10.00 | $2.000000 | 0% | Dec 2023 |
|
Bank of America Corporation | 6.00 | $1.000200 | 0% | Dec 2023 |
|
UBS Group | 5.00 | $1.000000 | -94% | Dec 2023 |
|
Who sold out of Aptevo Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
T. Rowe Price Associates | Sep 2023 | 46k | $16k |
Earnest Partners | Sep 2023 | 14.00 | $4.999400 |